Cargando…
Nutraceuticals as therapeutic agents for atherosclerosis
Atherosclerosis, a chronic inflammatory disorder of medium and large arteries and an underlying cause of cardiovascular disease (CVD), is responsible for a third of all global deaths. Current treatments for CVD, such as optimized statin therapy, are associated with considerable residual risk and sev...
Autores principales: | Moss, Joe W.E., Williams, Jessica O., Ramji, Dipak P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Pub. Co
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906642/ https://www.ncbi.nlm.nih.gov/pubmed/29454074 http://dx.doi.org/10.1016/j.bbadis.2018.02.006 |
Ejemplares similares
-
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
por: Ramji, Dipak P., et al.
Publicado: (2015) -
The interleukin-33-mediated inhibition of expression of two key genes implicated in atherosclerosis in human macrophages requires MAP kinase, phosphoinositide 3-kinase and nuclear factor-κB signaling pathways
por: Buckley, Melanie L., et al.
Publicado: (2019) -
A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro
por: Moss, Joe W. E., et al.
Publicado: (2016) -
The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease
por: Alalawi, Sulaiman, et al.
Publicado: (2023) -
Nutraceuticals as potential therapeutic agents for colon cancer: a review
por: Kuppusamy, Palaniselvam, et al.
Publicado: (2014)